Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The closing price of Atossa Therapeutics Inc (NASDAQ: ATOS) was $0.83 for the day, down -5.63% from the previous closing price of $0.88. In other words, the price has decreased by -$5.63 from its previous closing price. On the day, 0.74 million shares were traded. ATOS stock price reached its highest trading level at $0.91 during the session, while it also had its lowest trading level at $0.83.
Ratios:
Our analysis of ATOS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 12.67 and its Current Ratio is at 12.67. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on January 26, 2018, initiated with a Buy rating and assigned the stock a target price of $2.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 21 ’25 when QUAY STEVEN C bought 11,239 shares for $0.88 per share. The transaction valued at 9,887 led to the insider holds 13,898 shares of the business.
Remmel H. Lawrence bought 10,000 shares of ATOS for $7,000 on Mar 26 ’25. The Director now owns 10,257 shares after completing the transaction at $0.70 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATOS now has a Market Capitalization of 107211096 and an Enterprise Value of 42095104.
Stock Price History:
The Beta on a monthly basis for ATOS is 0.92, which has changed by -0.28448278 over the last 52 weeks, in comparison to a change of 0.12632763 over the same period for the S&P500. Over the past 52 weeks, ATOS has reached a high of $1.66, while it has fallen to a 52-week low of $0.55. The 50-Day Moving Average of the stock is -0.89%, while the 200-Day Moving Average is calculated to be -17.71%.
Shares Statistics:
ATOS traded an average of 977.54K shares per day over the past three months and 2386800 shares per day over the past ten days. A total of 129.17M shares are outstanding, with a floating share count of 129.12M. Insiders hold about 0.04% of the company’s shares, while institutions hold 26.47% stake in the company. Shares short for ATOS as of 1749772800 were 7415914 with a Short Ratio of 7.59, compared to 1747267200 on 7138285. Therefore, it implies a Short% of Shares Outstanding of 7415914 and a Short% of Float of 5.74.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The dynamic stock of Atossa Therapeutics Inc (ATOS) is currently attracting attention from 3.0 analysts actively involved in rating its market status.The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.05 and low estimates of -$0.06.
Analysts are recommending an EPS of between -$0.21 and -$0.24 for the fiscal current year, implying an average EPS of -$0.23. EPS for the following year is -$0.27, with 3.0 analysts recommending between -$0.25 and -$0.29.
